Dobutamine-Claris dobutamine (as hydrochloride) 250 mg/ 20 mL concentrated solution for injection ampoule 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

dobutamine-claris dobutamine (as hydrochloride) 250 mg/ 20 ml concentrated solution for injection ampoule

baxter healthcare pty ltd - dobutamine hydrochloride, quantity: 14.01 mg/ml (equivalent: dobutamine, qty 12.5 mg/ml) - injection, concentrated - excipient ingredients: sodium metabisulfite; hydrochloric acid; sodium hydroxide; water for injections - adults who require short-term treatment of cardiac failure secondary to acute myocardial infarction, or cardiac surgery.???

DOBUTAMINE 12.5 Mg/Ml Concentrate for Soln for Inf 爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

dobutamine 12.5 mg/ml concentrate for soln for inf

claris lifesciences (uk) limited - dobutamine hydrochloride - concentrate for soln for inf - 12.5 mg/ml - adrenergic and dopaminergic agents

DOBUTAMINE INJECTION SDZ SOLUTION 加拿大 - 英文 - Health Canada

dobutamine injection sdz solution

sandoz canada incorporated - dobutamine (dobutamine hydrochloride) - solution - 12.5mg - dobutamine (dobutamine hydrochloride) 12.5mg - selective beta 1-adrenergic agonists

DOBUTAMINE INJECTION USP SOLUTION 加拿大 - 英文 - Health Canada

dobutamine injection usp solution

hikma canada limited - dobutamine (dobutamine hydrochloride) - solution - 12.5mg - dobutamine (dobutamine hydrochloride) 12.5mg - selective beta 1-adrenergic agonists

DOBUTAMINE SANDOZ dobutamine 250mg/20mL (as hydrochloride) injection ampoule 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

dobutamine sandoz dobutamine 250mg/20ml (as hydrochloride) injection ampoule

sandoz pty ltd - dobutamine hydrochloride, quantity: 14 mg/ml (equivalent: dobutamine, qty 12.5 mg/ml) - injection, concentrated - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections; sodium metabisulfite - adults who require short-term treatment of cardiac failure secondary to acute myocardial infarction, or cardiac surgery.

DOBUTAMINE INJECTION USP SOLUTION 加拿大 - 英文 - Health Canada

dobutamine injection usp solution

pfizer canada ulc - dobutamine (dobutamine hydrochloride) - solution - 250mg - dobutamine (dobutamine hydrochloride) 250mg - selective beta 1-adrenergic agonists

Dobutamine 新西兰 - 英文 - Medsafe (Medicines Safety Authority)

dobutamine

rex medical ltd - dobutamine hydrochloride 14.01 mg/ml equivalent to dobutamine 12.5 mg/ml;   - concentrate for infusion - 250 mg/20ml - active: dobutamine hydrochloride 14.01 mg/ml equivalent to dobutamine 12.5 mg/ml   excipient: hydrochloric acid sodium hydroxide sodium metabisulfite water for injection - dobutamine is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. conditions which may precipitate such situations include the following hypoperfusion states: initially cardiac in origin a. acute heart failure 1. acute myocardial infarction 2. cardiogenic shock 3. following cardiac surgery 4. medicine-induced depression of cardiac contractility such as that which occurs in excessive ?- adrenergic receptor blockade. b. chronic heart failure 1. acute decompensation of chronic congestive heart failure 2. temporary inotropic support in advanced chronic congestive heart failure, as an adjunct to therapy with conventional oral inotropic agents, systemic vasodilators, and diuretics. initially noncardiac in origin 1. acute hypoperfusion states secondary to trauma, surgery, sepsis, or hypovolaemia when mean arterial pressure is above 70-mm hg and pulmonary capillary wedge pressure is 18-mm hg or greater, with inadequate response to volume repletion and increased ventricular filling pressure 2. low cardiac output secondary to mechanical ventilation with positive end-expiratory pressure (peep). dobutamine is indicated in all paediatric age groups (from neonates to 18 years of age) as inotropic support in low cardiac output hypoperfusion states resulting from decompensated heart failure, following cardiac surgery, cardiomyopathies and in cardiogenic or septic shock.

DOBUTAMINE INJECTION USP SOLUTION 加拿大 - 英文 - Health Canada

dobutamine injection usp solution

sterimax inc - dobutamine (dobutamine hydrochloride) - solution - 12.5mg - dobutamine (dobutamine hydrochloride) 12.5mg - selective beta 1-adrenergic agonists